Stock·NYSE·Consumer Cyclical
XPeng Inc (XPEV)
- Market cap
- $8.64B
- Dividend yield
- None
- Street target
- $18.18median of 25 analysts
- 52-week range
- $8.94 $28.24
XPEV stock forecast today
Where XPEV stands today, and what CleaRank Financial AI makes of it.
XPEV at a glance
XPeng Inc (XPEV): Sell, 30/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($10.15 and $14.47).
Figures as of October 30, 2026.
CleaRank Financial AI
CleaRank rates XPeng Inc (XPEV) Sell, with a model score of 30/100.
The analysts' outlook lifts the score most: 19 of 25 analysts rate it a buy and the median target is 101.6% above the price. The trend holds it back most: the price is 37.68% below its 200-day average and 11.17% below its 50-day average, and the 50-day average is 29.84% below the 200-day. The 50-day average stands at $10.15 and the 200-day at $14.47. Over the past year the price fell 60.70%.
Only on CleaRank
Figures we compute ourselves from XPEV's own price, earnings and insider-filing history. Tap one to see it in context.
XPEV stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price below its 50-day average ›
The price of $9.02 is 11.2% below the 50-day simple moving average of $10.15.Price below its 200-day average ›
The price is 37.7% below the 200-day simple moving average of $14.47.50-day average below the 200-day ›
The 50-day average ($10.15) is 29.8% below the 200-day average ($14.47), the arrangement of a falling longer-term trend.In the lower half of its 52-week range ›
The price sits at 0% of its 52-week range, between $8.94 and $28.24.
XPEV share price
Pick a period: each tab shows how far XPEV has moved over it, to the last close.
Today's trading
Where XPEV sits inside today's range and its 52-week range.
XPEV fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
1/2P/S below the sector median ›
The price-to-sales ratio of 0.76 is 59.8% below the sector median of 1.9.Not profitable over the last 12 months ›
Net income over the last 12 months was -$468.1M on revenue of $11.3B, a net margin of -4.1%.
Key statistics
The headline figures for XPEV.
As of October 30, 2026, XPEV trades at $9.02, with a market value of $8.64B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of XPEV's valuation, growth and risks.
XPeng Inc (XPEV) has no meaningful P/E, not meaningful, since its earnings per share over the last 12 months are negative. Against sales, its P/S of 0.76 sits 60.0% below the sector median of 1.9. Its market value stands at $8.6B.
XPEV is losing money. Its net margin is -4.14% and its operating margin is -6.03%, while return on equity of -10.88% sits below the sector median of 12.4%. Debt-to-equity comes in at 0.99.
Analysts forecast EPS of -$3.68 for this fiscal year, and -$0.24 for the year after.
XPEV's daily returns have a 30-day standard deviation of 2.63%, and its beta against the S&P 500 is 1.07. Risk is also tied to the trend: for as long as the price remains beneath both moving averages, the downtrend itself carries risk. At present the price is 68.05% under its 52-week high of $28.24.
XPEV against the Consumer Cyclical sector
How XPEV compares with the median Consumer Cyclical stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, XPEV trades at 0.7634x, -60% versus the sector average of 1.90x.
Return vs SPY: Since May 20, 2025, XPEV has lost 54.2% against a gain of 27.5% for SPY.
Performance against SPY
XPEV and the S&P 500 (SPY) over the same days.
Revenue and earnings
How much XPEV sells, and how much of it becomes profit.
The quarterly bars end with Q1 '26 (the quarter to March 31, 2026); XPEV reported again on August 24, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 87.7% in FY2025 to CN¥76.7B, from CN¥40.9B a year earlier.
Profit margin: The net margin was -1.5% in FY2025, up from -14.2% the year before.
Loss-making: XPEV lost CN¥1.1B in FY2025.
XPEV AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 39.1, showing bearish momentum without being oversold.RSI below 50 ›
An RSI of 39.1 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line below zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of XPEV
The score, the reasoning behind it, and what could move the price next.
XPeng Inc (XPEV) trades at $9.02, under both of its main moving averages. The price is 11.17% below its 50-day average of $10.15 and 37.68% below the 200-day at $14.47. Sitting at 0% of its 52-week range, the stock is 0.89% above the 52-week low of $8.94. The 50-day average is 29.84% below the 200-day, which backs up the weakness instead of disputing it.
On momentum, the 14-day RSI reads 39.1, in the bearish zone, above the oversold line, with the MACD line negative. The recent returns all show a loss, with the price down 30.62% over the past three months, 43.02% over the past six months and 60.70% over the past year. The price fell 1.74% in the last session on volume 87.0% above its average.
Analyst upgrade ›
Macquarie upgraded it to Outperform from Neutral on May 29, 2026.
Source: Analyst action, Macquarie, May 29, 2026
Analyst downgrade ›
JP Morgan downgraded it to Neutral from Overweight on September 29, 2026.
Source: Analyst action, JP Morgan, September 29, 2026
- The two closest levels to track are the 20-day EMA at $9.45, which sits above the price, and the 52-week low at $8.94, which sits below it.
- The 14-day RSI is 39.1, which falls in the bearish zone, and the MACD line is negative. Readings above 70 or below 30 would signal stretched momentum.
XPEV stays in a downtrend for as long as it trades below both its 50-day average at $10.15 and its 200-day average at $14.47. A close above the 50-day would be the first sign of a repair. Overhead, the 20-day EMA at $9.45 is the first hurdle.
Below the price, the nearest floor is the 52-week low at $8.94. With the RSI in the bearish band, a fast rebound looks harder to achieve.
Technical indicators
Momentum and trend for XPEV, from its daily closes.
As of October 30, 2026, with XPEV at $9.02, its 14-day RSI is 39.1 (showing bearish momentum without being oversold), its 50-day simple moving average is $10.15 and its 200-day is $14.47.
Calculated by CleaRank on daily closes as of October 30, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What XPEV moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 30, 2026, XPEV's 1-year correlation of daily returns is +0.24 with S&P 500 (SPY), +0.24 with Nasdaq 100 (QQQ), +0.15 with Bitcoin (BTC) and +0.15 with gold (XAU).
XPEV price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
19 of 25 analysts rate it a buy or strong buy, 4 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $18.18 is 101.6% above the price.No more buy ratings than three months ago ›
19 of 25 rate it a buy now, against 21 of 26 three months ago.
XPEV Wall Street View
12-month price targets
The price, $9.02, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 29, 2026 | JP Morgan | Downgrade | Neutral |
| Aug 26, 2026 | Barclays | Maintains | Underweight |
| Aug 25, 2026 | JP Morgan | Maintains | Overweight |
| Jul 16, 2026 | Barclays | Maintains | Underweight |
| May 29, 2026 | Macquarie | Upgrade | Outperform |
As of October 30, 2026, 25 Wall Street analysts cover XPEV: 19 rate it a buy or strong buy, 4 a hold and 2 a sell or strong sell. Their 12-month price targets range from $11.03 to $25.43. The median XPEV price target is $18.18, 101.6% above the price of $9.02.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
XPEV trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
XPEV trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from XPEV's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much XPEV tends to move, against the market and on its own.
XPEV price history and drawdowns
XPEV's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move of 2% or more ›
The price has moved 2.63% on an average day (30-day standard deviation of daily returns).Not yet recovered from its worst fall ›
The worst fall was 88.8%, from November 2020 to November 2022; the price is still 84.6% below that peak.Most 1-year holds did not end higher ›
37% of 1-year holding periods in the last 6 years ended with a gain.Trailed the S&P 500 since the chart begins ›
$10,000 invested in August 2020 is now worth $4,326, against $24,037 in the S&P 500 (SPY).
XPEV Drawdowns & Recovery
As of October 30, 2026, XPEV's worst peak-to-trough fall over the last 6 years with dividends reinvested was -88.8% (November 2020 to November 2022); it is still 84.6% below that peak, and 37% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into XPEV in August 2020 is worth now, against the same amount in the S&P 500.
Against the market: XPEV trailed the S&P 500 over this period: $4,326.11 against $24,037.
A $10,000 investment in XPEV in August 2020 would be worth about $4,326 today with dividends reinvested, compared with about $24,037 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to XPEV, and which have not.
Strongest month, November: an average of +36.79%, up in 4 of 6 years.
Weakest month, September: an average of -7.49%, up in 1 of 7 years.
This month, October: has averaged -0.64%, up in 4 of 6 years. Past seasonality does not repeat on schedule.
Over the last 7 years, XPEV's strongest calendar month has been November (average +36.79%, up in 4 of 6 years) and its weakest September (average -7.49%, up in 1 of 7 years).
Average return for each calendar month over the last 7 years, from weekly closing prices with dividends included.
XPEV stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in XPEV, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 6 years of price history, projects that a $10,000 investment in XPEV today could grow to about $8,407 by 2030 in the base case, with a 90th-percentile outcome near $30,286 and a 10th-percentile outcome around $2,334. Projections are statistical simulations, not guarantees.
XPEV Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $7.58 for XPEV by 2030 in the base case, from $9.02 today (0.8x over 4 years). The 10th-percentile path ends near $2.11. These are outcomes of a Monte Carlo simulation run on XPEV's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $4.55 | $8.64 | $16.39 | |
| 2028 | $3.34 | $8.27 | $20.47 | |
| 2029 | $2.61 | $7.92 | $24.03 | |
| 2030 | $2.11 | $7.58 | $27.32 |
Method: a lognormal simulation of XPEV's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
XPEV stock forecast: questions people ask
Answered from the figures on this page, as of October 30, 2026.